GM-CSF Neutralization With Lenzilumab in Severe COVID-19 Pneumonia: A Case-Cohort Study

Temesgen, Z; Assi, M; Shweta, FNU; Vergidis, P; Rizza, SA; Bauer, PR; Pickering, BW; Razonable, RR; Libertin, CR; Burger, CD; Orenstein, R; Vargas, HE; Palraj, R; Dababneh, AS; Chappell, G; Chappell, D; Ahmed, O; Sakemura, R; Durrant, C; Kenderian, SS; Badley, AD

Temesgen, Z (corresponding author), Mayo Clin, Div Infect Dis, 200 First St SW, Rochester, MN 55905 USA.

MAYO CLINIC PROCEEDINGS, 2020; 95 (11): 2382

Abstract

Objective: To assess the efficacy and safety of lenzilumab in patients with severe coronavirus disease 2019 (COVID-19) pneumonia. Methods: Hospitalize......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索